These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 766284)

  • 21. Opsonization.
    Peltier AP
    Nouv Rev Fr Hematol; 1974; 14(2):247-57. PubMed ID: 4277246
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.
    Blaser MJ; Smith PF; Repine JE; Joiner KA
    J Clin Invest; 1988 May; 81(5):1434-44. PubMed ID: 3366901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary opsonins in Klebsiella pneumoniae pneumonia in rats.
    Coonrod JD
    Infect Immun; 1981 Aug; 33(2):533-9. PubMed ID: 7024132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement, opsonins, and the immune response to bacterial infection in burned patients.
    Bjornson AB; Altemeier WA; Bjornson HS
    Ann Surg; 1980 Mar; 191(3):323-9. PubMed ID: 6767453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal familial Leiner's disease: a deficiency of the opsonic activity of serum complement.
    Jacobs JC; Miller ME
    Pediatrics; 1972 Feb; 49(2):225-32. PubMed ID: 4258194
    [No Abstract]   [Full Text] [Related]  

  • 29. Opsonins.
    N Engl J Med; 1970 Feb; 282(7):391-2. PubMed ID: 4903824
    [No Abstract]   [Full Text] [Related]  

  • 30. Humoral immune function and experimental Escherichia coli infection in splenectomized dogs.
    Dankó I
    Acta Microbiol Acad Sci Hung; 1982; 29(3):173-9. PubMed ID: 6762815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phagocytosis as a surface phenomenon. II. Contact angles and phagocytosis of encapsulated bacteria before and after opsonization by specific antiserum and complement.
    Van Oss CJ; Gillman CF
    J Reticuloendothel Soc; 1972 Nov; 12(5):497-502. PubMed ID: 4120360
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis.
    Cutler CW; Arnold RR; Schenkein HA
    J Immunol; 1993 Dec; 151(12):7016-29. PubMed ID: 8258706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunology of pyelonephritis in the primate model. VI. Effect of complement depletion.
    Roberts JA; Roth JK; Domingue G; Lewis RW; Kaack B; Baskin G
    J Urol; 1983 Jan; 129(1):193-6. PubMed ID: 6338249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum opsonins and chemotactins in neutropenic oncology patients.
    Stempel DA; Eden OB; Gilkerson E; Berberich FR
    Transfusion; 1979; 19(3):345-7. PubMed ID: 452075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae.
    Coonrod JD; Yoneda K
    Rev Infect Dis; 1981; 3(2):310-22. PubMed ID: 7256089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the complement system during infections due to gram-negative bacteria.
    Füst G; Petrás G; Ujhelvi E
    Clin Immunol Immunopathol; 1976 May; 5(3):293-302. PubMed ID: 776471
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of easily released substances (ERS) from bacteria into physiologic solutions in natural immunity. IV. The action of ERS from E. coli O 55 and O 111 on opsonins for Staphylococcus aureus in guinea pig sera.
    Grzybek-Hryncewicz K; Zielska U
    Arch Immunol Ther Exp (Warsz); 1974; 22(5):571-4. PubMed ID: 4614755
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.
    Björkstén B; Bortolussi R; Gothefors L; Quie PG
    J Pediatr; 1976 Dec; 89(6):892-7. PubMed ID: 792409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
    Zaragoza O; Casadevall A
    Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.